Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Clinical trial NCT06834672 · RECRUITING
Trial details
- NCT number
- NCT06834672
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2027-12-28
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.